314 related articles for article (PubMed ID: 16151383)
1. R&D deals boom in 2004.
Lawrence S
Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
[No Abstract] [Full Text] [Related]
2. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
3. Biotech drugs come of age; policymakers take notice.
Iglehart JK
Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
[No Abstract] [Full Text] [Related]
4. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
5. Today's biotech industry in India.
Suresh N
Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
[No Abstract] [Full Text] [Related]
6. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
7. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
8. Stepping up to the plate.
Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245
[No Abstract] [Full Text] [Related]
9. Biotech boom.
Jayaraman KS
Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
[No Abstract] [Full Text] [Related]
10. A testing approach based on tiny doses still awaits big results.
Coombs A
Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
[No Abstract] [Full Text] [Related]
11. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
12. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
13. 25 top health care stocks. Will they lead the next market boom?
Kane L
Med Econ; 2001 Apr; 78(7):126-8, 133-6, 140-2. PubMed ID: 11368040
[No Abstract] [Full Text] [Related]
14. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
Tear S; Zarkowska T
IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
[No Abstract] [Full Text] [Related]
15. IPO floodgates unlikely to open after Ark floatation.
Louët S
Nat Biotechnol; 2004 Apr; 22(4):367-8. PubMed ID: 15060538
[No Abstract] [Full Text] [Related]
16. The number on biotech indexes.
Jacobs T
Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
[No Abstract] [Full Text] [Related]
17. SNP market view: opportunities, technologies, and products.
Wypgant M
Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
[No Abstract] [Full Text] [Related]
18. Biotech industry tries to recover from 2-year lull.
Brower V
J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
[No Abstract] [Full Text] [Related]
19. Biotech boom.
Jayaraman KS
Nat Biotechnol; 2005 Sep; 23(9):1183-4. PubMed ID: 16151411
[TBL] [Abstract][Full Text] [Related]
20. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
Persidis A; Persidis A
Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
[No Abstract] [Full Text] [Related]
[Next] [New Search]